FDA Advisors Question Abbott's Dissolving Heart Stent

Mar 15, 2016

Reuters

Abbott Labs is seeking FDA approval to sell a novel coronary stent that dissolves after it is implanted, but government scientists have raised questions about potential heart attack and blood clots risks.

The stent, called Absorb, is an alternative to metal stents currently used to prop open arteries cleared of blockages. The stent disappears within three years of the procedure.

An FDA advisory panel meets on Tuesday to consider whether to recommend approval of Absorb. The panel will question data showing more heart attack and stent-related blood clots compared with Abbott’s drug-coated metal Xience stent, as well as address risks associated with the device when used in smaller arteries.

Read the Reuters article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments